Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
open role · lever:capricor
Facilities Manager
ManagerRare DiseaseCell & Gene Therapy
🐶 see how you match
Upload your résumé and Bork scores this role against your skills, level, and therapeutic-area fit — then sends you new matches every morning.
get your match score →skills Bork detected
Cell & Gene Therapy
sourced from lever:capricor · pharmadog never charges to apply